Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non–small cell lung cancer (NSCLC) treated with definitive radiation therapy.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Emily S. Lebow, Yonina R. Murciano-Goroff, Justin Jee, Ekaterina Kalashnikova, Jordan Feeney, Himanshu Sethi, Alexey Aleshin, Mark G. Kris, Jamie E. Chaft, Charles M. Rudin, David Randolph Jones, Pedram Razavi, Jorge S. Reis-Filho, Daniel Richard Gomez, Daphna Y. Gelblum, Narek Shaverdian, James M. Isbell, Bob T. Li, Andreas Rimner
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4281660686